ClinicalTrials.Veeva

Menu
C

Centennial Medical Group | Elkridge, MD

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Semaglutide
LY3298176
Testosterone
Tirzepatide
JNJ-42847922
Sitagliptin
IW-3718
Triglyceride
Ritonavir
Bococizumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

10 of 47 total trials

A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight

This study will look at how a new medicine called NNC0519-0130 helps people with excess body weight lose weight. The study will test up to 6 differen...

Enrolling
Obesity
Drug: Placebo
Drug: Tirzepatide

This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additiona...

Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Tirzepatide

The purpose of this study is to evaluate the safety and immunogenicity in parallel of heptavalent mRNA-1975 and monovalent mRNA-1982 against Lyme dis...

Active, not recruiting
Lyme Disease
Biological: Placebo
Biological: mRNA-1975

The purpose of this clinical study is to learn about the safety, extent of the side effects (reaction to vaccine), and immune response (your immune s...

Enrolling
Shingles
Human
Biological: Selected Vaccine Candidate group (Dose level, Schedule)
Biological: Shingrix - SSB

The purpose of this clinical trial is to learn about a pneumococcal vaccine with a new ingredient (PF-07872411) intended to enhance the effects of th...

Active, not recruiting
Pneumococcal Disease
Biological: Standard dose multivalent pneumococcal conjugate vaccine control
Biological: Low dose of multivalent pneumococcal conjugate vaccine control

The primary objective of this study is to assess the effect of enobosarm on total lean mass as measured by DEXA in patients maintained on GLP-1 recep...

Enrolling
Obesity
Muscle Loss
Drug: Semaglutide
Drug: Enobosarm

This is a Phase 3 Randomized Double-Blind Placebo-Controlled 6-month Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Ob...

Enrolling
OSA
Drug: Placebo
Drug: AD109

The goal of this randomised, double-blind phase II/III clinical trial is to determine the safety and efficacy of IHL-42X in subjects with obstructive...

Enrolling
Obstructive Sleep Apnea
Drug: Placebo
Drug: Acetazolamide

The purpose of AROAPOC3-3001 is to evaluate the efficacy and safety of ARO-APOC3 plozasiran) in adult participants with familial chylomicronemia synd...

Active, not recruiting
Familial Chylomicronemia
Drug: Placebo
Drug: Plozasiran

This is a Phase 3, randomized, parallel-group, comparator-controlled, observer-blind, multicenter study of immunogenicity and safety in approximately...

Active, not recruiting
Influenza, Human
Biological: licensed QIV1
Biological: licensed QIV2

Trial sponsors

Exact Sciences Corporation logo
Pfizer logo
Janssen (J&J Innovative Medicine) logo
Lilly logo
Novo Nordisk logo
AbbVie logo
Janssen (J&J Innovative Medicine) logo
Apnimed logo
Arrowhead Pharmaceuticals logo
AstraZeneca logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems